Comparison of efficacy of add-on therapy of teneligliptin versus pioglitazone among type 2 diabetes mellitus patients ineptly controlled on dual therapy of metformin plus sulfonylurea

Comparison of efficacy of add-on therapy of teneligliptin versus pioglitazone among type 2 diabetes mellitus patients ineptly controlled on dual therapy of metformin plus sulfonylurea

Aim: The main aim of the study is to compare the efficacy of add-on therapy of teneligliptin (20 once daily) versus pioglitazone (15 mg once daily) among type 2 diabetes mellitus (T2DM) patients inadequately controlled on dual therapy of metformin (MF) plus sulfonylurea (SU). Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Vanjari Nikhil Kumar, Sandeep Reddy Konyala, Siva Subrahmanyam Bandaru, Goverdhan Puchchakayala
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Diabetology
Subjects:
Dipeptidyl peptidase 4 inhibitors
thiazolidinedione
glycated haemoglobin
glycaemic control
lipid profile
peroxisome proliferator-activated receptors
type 2 diabetes mellitus
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2019;volume=10;issue=2;spage=76;epage=82;aulast=Kumar

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2019;volume=10;issue=2;spage=76;epage=82;aulast=Kumar

Similar Items